{
    "2018-03-06": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Are Alzheimer's-Focused Stocks Set for a Financial Windfall?",
                "features": {
                    "keywords": [
                        "Alzheimer's",
                        "Financial Windfall"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson’s Revenues in 4Q17",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Revenues",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Novo Nordisk Has a Broad Portfolio for Type 2 Diabetes Care",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Type 2 Diabetes",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-15",
                "original_text": "Diabetes Care Segment Continues to Drive Growth for NVO in 2018",
                "features": {
                    "keywords": [
                        "Diabetes Care",
                        "Growth",
                        "NVO",
                        "2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-15",
                "original_text": "Novo Nordisk Focuses on Raising the Bar in Research in 2018",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Research",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "How Bristol-Myers Squibb’s Opdivo Performed",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "Opdivo",
                        "Performed"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "How Did Bristol-Myers Squibb Perform in 4Q17 and Fiscal 2017?",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "4Q17",
                        "Fiscal 2017"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials",
                "features": {
                    "keywords": [
                        "Boehringer Ingelheim",
                        "Lilly",
                        "heart failure",
                        "Jardiance®",
                        "exercise capacity trials"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}